Fontana, Pierre

 
Title Year Hits Downloads
Assessing aspirin responsiveness using the Verify Now Aspirin assay 2008 262 1
Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis 2008 272 1
Laboratory-defined aspirin resistance and recurrent cardiovascular events 2008 239 0
Aspirin "resistance" and risk of cardiovascular morbidity 2008 211 1
Aspirin response variability assessed with the PFA-100 device 2008 250 0
Impending paradoxical embolism. When and how to treat? 2008 255 1
Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19*2 allele on clopidogrel responsiveness 2008 223 0
Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided? 2009 214 0
Intercellular communication in atherosclerosis 2009 248 0
No influence of the VAMP8 rs1010 single nucleotide polymorphism on platelet functions in vitro 2009 217 0
Diagnosis of mild bleeding disorders 2009 289 924
Cell-derived microparticles in haemostasis and vascular medicine 2009 224 0
Acute coronary syndrome and its antithrombotic treatment: focus on aspirin and clopidogrel resistance 2009 180 0
Le concept de "resistance" a l'aspirine: mecanismes et pertinence clinique 2009 235 0
Antiagregants plaquettaires : lequel, quand et pour qui ? 2010 216 0
Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study 2010 237 0
Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis 2010 177 0
Evaluation de l'efficacité biologique du clopidogrel: génotype ou phénotype? 2010 193 0
Maladies cardiovasculaires, antiagrégants, anticoagulants et risque hémorragique 2010 252 0
Hémostase. Le point sur les nouveaux antithrombotiques 2010 238 0
Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variability 2010 278 0
The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin 2011 231 0
Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study 2011 246 0
Connexin 37 limits thrombus propensity by downregulating platelet reactivity 2011 310 408
Surveillance biologique des héparines et du fondaparinux 2011 249 2
Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients 2011 271 1
Aspirin for venous thromboembolism prevention and treatment: a renewal? 2012 238 100
The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro 2012 199 0
Platelet proteomics 2012 228 2
Prevalence of poor biological response to clopidogrel: a systematic review 2012 182 0
Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis 2012 242 0
Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study 2012 288 3
Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management 2012 253 0
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013 2013 194 0
Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk-guided management 2013 255 0
Unraveling modulators of platelet reactivity incardiovascular patients using omics strategies: Towards anetwork biology paradigm 2013 267 222
Gestion péri-interventionnelle des nouveaux agents antiplaquettaires 2013 269 140
Tailored Thienopyridine therapy: no urgency for CYP2C19 genotyping 2013 169 0
Hémostase : nouveaux anticoagulants oraux : de la théorie à la pratique 2013 100 0
The Human Diabetes Proteome Project (HDPP): From network biology to targets for therapies and prevention 2013 254 17
Antiplaquettaires et patients âgés : quelles molécules et quelles preuves ? 2013 237 1
Gestes invasifs et patients sous anticoagulants oraux : to bridge or not to bridge ? 2013 253 1
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 2014 275 1
Impact of high glucose concentration on aspirin-induced acetylation of human serum albumin: An in vitro study 2014 110 31
Evaluation of the GEM®PCL Plus point-of-care device for neonatal coagulation assessment: An observational study on cord blood 2014 196 2
Fibrinogen geneva II: a new congenitally abnormal fibrinogen alpha chain (Gly17Asp) with a review of similar mutations resulting in abnormal knob A. 2014 262 3
Direct oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolism 2014 253 128
Antiplatelet Therapy: Targeting the TxA2 Pathway 2014 238 2
Role of paraoxonase-1 in CYP2C19 loss-of-function carriers 2014 263 0
Characterization of the platelet granule proteome: Evidence of the presence of MHC1 in alpha-granules 2014 363 3
Hémostase. Aspirine: une ou deux fois par jour? 2014 293 2
How to manage prasugrel and ticagrelor in daily practice 2014 121 90
Refinement of the cutoff values of the HemosIL AcuStar assay for the detection of anticardiolipin and anti-beta2 glycoprotein-1 antibodies 2014 238 0
Sputtered titanium oxynitride coatings for endosseous applications: Physical and chemical evaluation and first bioactivity assays 2014 346 1
Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-Review 2015 252 4
The Human Diabetes Proteome Project (HDPP): The 2014 update 2015 154 78
Functional role of a polymorphism in the Pannexin1 gene in collagen-induced platelet aggregation 2015 191 8
Direct oral anticoagulants: efficacy and safety in patient subgroups 2015 322 179
Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo study 2015 213 0
Lack of Effect of Platelet Transfusions and Desmopressin on Intracranial Bleeding in a Patient Receiving Ticagrelor 2015 197 1
Reply to: "The role of platelets in liver regeneration - What don't we know?" 2015 120 0
Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalisation with an external reference plasma 2015 148 102
Fibrin degradation during sonothrombolysis – Effect of ultrasound, microbubbles and tissue plasminogen activator 2015 227 0
Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants 2015 168 101
Suspicion of heparin-induced thrombocytopenia in internal medicine: How appropriate is the ordering of anti-PF4/heparin antibody testing? 2015 248 2
Antiplatelet drugs and platelet reactivity: is it time to halt clinical research on tailored strategies? 2015 290 1
Laboratory testing of Hemostasis 2015 93 73
Characterisation of the influences of aspirin-acetylation and glycation on human plasma proteins 2015 302 1
A focus on the role of platelets in liver regeneration: do platelet-endothelial cell interactions initiate the regenerative process? 2015 261 0
Aspirin-mediated acetylation of haemoglobin increases in presence of high glucose concentration and decreases protein glycation 2015 112 74
News in angiology and hemostasis 2016 225 78
Modulation of osteoblast behavior on TiNxOy coatings by altering the N/O stoichiometry while maintaining a high thrombogenic potential 2016 195 3
Correction of prasugrel-related bleeding by prophylactic transfusion of human platelets in a rabbit model 2016 119 2
Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data 2016 180 2
Effect of long-term adherence to clopidogrel on the VASP-PRI after elective coronary stent implantation: a randomized controlled study 2016 126 0
New molecular insights into modulation of platelet reactivity in aspirin-treated patients using a network-based approach 2016 266 6
Genetic testing to identify women at risk of venous thromboembolism with contraceptive pills: Evidence or hope-based tool ? 2016 180 60
Direct oral anticoagulants: a guide for daily practice 2016 330 142
Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect 2016 97 33
Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach 2016 185 116
La maladie thromboembolique veineuse : une pathologie souvent oubliée 2016 61 16
Pharmacogenomics of Oral Antithrombotic Drugs 2016 240 0
Genetics of clopidogrel poor-response 2016 151 0
Anticoagulants oraux directs (ACOD) : une aide à la prescription dans la pratique quotidienne 2016 77 18
Aspirin response: Differences in serum thromboxane B2 levels between clinical studies 2016 265 1
PPM1A Methylation Is Associated With Vascular Recurrence in Aspirin-Treated Patients 2016 127 0
Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis 2016 305 141
TRAF3 Epigenetic Regulation Is Associated With Vascular Recurrence in Patients With Ischemic Stroke 2016 127 0
Subthalamic nucleus deep brain stimulation for Parkinson's disease in a patient with severe haemophilia A. 2017 86 0
Impact of rivaroxaban on point-of-care assays 2017 106 0
TiN x O y coatings facilitate the initial adhesion of osteoblasts to create a suitable environment for their proliferation and the recruitment of endothelial cells 2017 126 2
Platelets in liver regeneration 2017 92 3
Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015 2017 130 0
Comparative Long-Term Effect of Three Anti-P2Y12 Drugs after Percutaneous Angioplasty: An Observational Study Based on Electronic Drug Adherence Monitoring 2017 96 10
Pannexin- and Connexin-Mediated Intercellular Communication in Platelet Function 2017 125 47
Impact of pneumatic tube system transport for the monitoring of heparin therapy 2017 83 0
Pannexin1 Single Nucleotide Polymorphism and Platelet Reactivity in a Cohort of Cardiovascular Patients 2017 139 1
Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients? 2017 91 0
Impact of a product-specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study 2017 78 0
Platelet reactivity in stable cardiovascular patients with chronic kidney disease 2017 127 0
A multicenter study to assess the reproducibility of antiphospholipid antibody results produced by an automated system 2017 133 3
Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels 2017 79 0
Le défi des maladies vasculaires rares : l’union fait la force ! 2017 11 3
Angiologie et hémostase 2017 89 37
Thromboses veineuses splanchniques 2017 19 3
Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation 2017 94 0
Evaluation of recombinant factor VIIa, tranexamic acid and desmopressin to reduce prasugrel-related bleeding: A randomised, placebo-controlled study in a rabbit model 2018 104 4
Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT 2018 81 2
Effects of plasma transfusions on antithrombin levels after paediatric liver transplantation 2018 45 0
[Angiology and haemostasis. Highlights on some new data in 2017] 2018 12 2
Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites 2018 32 10
21335 3457